<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Peter</First><Last>Ghazal</Last></Person>
    <Email>ghazalp@cardiff.ac.uk</Email>
    <Department>Systems Immunity University Research Institute</Department>
    <Organization>Cardiff University</Organization>
    <Address>
      <Line>Sir Geraint Evans Building, Academic Avenue</Line>
      <City>Cardiff</City>
      <Postal-Code>CF14 4XN</Postal-Code>
      <Country>United Kingdom</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Organization></Organization>
    <Email>geo@ncbi.nlm.nih.gov, support@affymetrix.com</Email>
    <Phone>888-362-2447</Phone>
    <Organization>Affymetrix, Inc.</Organization>
    <Address>
      <City>Santa Clara</City>
      <State>CA</State>
      <Zip-Code>95051</Zip-Code>
      <Country>USA</Country>
    </Address>
    <Web-Link>http://www.affymetrix.com/index.affx</Web-Link>
  </Contributor>

  <Contributor iid="contrib3">
    <Organization>Illumina Inc.</Organization>
    <Email>expression@illumina.com, techsupport@illumina.com</Email>
    <Phone>1 800 809 4566 </Phone>
    <Organization>Illumina Inc.</Organization>
    <Address>
      <Line>9885 Towne Centre Drive</Line>
      <City>San Diego</City>
      <State>CA</State>
      <Zip-Code>92121</Zip-Code>
      <Country>USA</Country>
    </Address>
    <Web-Link>www.illumina.com</Web-Link>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Guoying</First><Last>Yu</Last></Person>
    <Email>yug@upmc.edu</Email>
    <Phone>412-648-8083</Phone>
    <Fax>412-624-7875</Fax>
    <Laboratory>Naftali Kaminski</Laboratory>
    <Department>Departmnet of Medicine</Department>
    <Organization>University of Pittsburgh</Organization>
    <Address>
      <Line>3500 Terrace St., W1200</Line>
      <City>Pittsburgh</City>
      <State>PA</State>
      <Zip-Code>15260</Zip-Code>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Paul</First><Last>Dickinson</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Claire</First><Middle>L</Middle><Last>Smith</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>Marie</First><Last>Craigon</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>Alan</First><Middle>J</Middle><Last>Ross</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>Mizanur</First><Middle>R</Middle><Last>Khondoker</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Thorsten</First><Last>Forster</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Alasdair</First><Last>Ivens</Last></Person>
  </Contributor>

  <Contributor iid="contrib12">
    <Person><First>David</First><Middle>J</Middle><Last>Lynn</Last></Person>
  </Contributor>

  <Contributor iid="contrib13">
    <Person><First>Judith</First><Last>Orme</Last></Person>
  </Contributor>

  <Contributor iid="contrib14">
    <Person><First>Allan</First><Last>Jackson</Last></Person>
  </Contributor>

  <Contributor iid="contrib15">
    <Person><First>Paul</First><Last>Lacaze</Last></Person>
  </Contributor>

  <Contributor iid="contrib16">
    <Person><First>Benjamin</First><Middle>J</Middle><Last>Stenson</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL570">
    <Status database="GEO">
      <Submission-Date>2003-11-07</Submission-Date>
      <Release-Date>2003-11-07</Release-Date>
      <Last-Update-Date>2019-03-25</Last-Update-Date>
    </Status>
    <Title>[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</Title>
    <Accession database="GEO">GPL570</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's web site

Complete coverage of the Human Genome U133 Set plus 6,500 additional genes for analysis of over 47,000 transcripts
All probe sets represented on the GeneChip Human Genome U133 Set are identically replicated on the GeneChip Human Genome U133 Plus 2.0 Array. The sequences from which these probe sets were derived were selected from GenBankÂ®, dbEST, and RefSeq. The sequence clusters were created from the UniGene database (Build 133, April 20, 2001) and then refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the University of California, Santa Cruz Golden-Path human genome database (April 2001 release).
In addition, there are 9,921 new probe sets representing approximately 6,500 new genes. These gene sequences were selected from GenBank, dbEST, and RefSeq. Sequence clusters were created from the UniGene database (Build 159, January 25, 2003) and refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the NCBI human genome assembly (Build 31).

    </Manufacture-Protocol>
    <Description>
Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://www.ncbi.nlm.nih.gov/projects/geo/info/geo_affy.html

June 03, 2009: annotation table updated with netaffx build 28
June 06, 2012: annotation table updated with netaffx build 32
June 23, 2016: annotation table updated with netaffx build 35
    </Description>
    <Web-Link>http://www.affymetrix.com/support/technical/byproduct.affx?product=hg-u133-plus</Web-Link>
    <Web-Link>http://www.affymetrix.com/analysis/index.affx</Web-Link>
    <Relation type="Alternative to" target="GPL4454" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL4866" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL5760" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6671" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6791" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6879" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL7567" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8019" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8542" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8715" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8712" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9102" comment="Probe Level Version" />
    <Relation type="Alternative to" target="GPL9099" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9101" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9324" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9486" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9987" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10175" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10335" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10371" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10526" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10881" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10925" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11084" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11433" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11670" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL13232" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 13.0.0]" />
    <Relation type="Alternative to" target="GPL13303" comment="Alternative CDF." />
    <Relation type="Alternative to" target="GPL13916" comment="[Brainarray ENSG Version 14.1]" />
    <Relation type="Alternative to" target="GPL14837" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL14877" comment="[Alternative CDF]" />
    <Relation type="Alternative to" target="GPL15394" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 14.0]" />
    <Relation type="Alternative to" target="GPL6732" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 7]" />
    <Relation type="Alternative to" target="GPL15445" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16066" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16100" comment="Alternative CDF [GATExplorer_Ensembl v57]" />
    <Relation type="Alternative to" target="GPL16268" comment="Alternative CDF [Brainarray ENSG Version 16]" />
    <Relation type="Alternative to" target="GPL16273" comment="Alternative CDF [Brainarray ENSG Version 15]" />
    <Relation type="Alternative to" target="GPL16311" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG Brainarray version 14.0.0]" />
    <Relation type="Alternative to" target="GPL16356" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG 15.0.0]" />
    <Relation type="Alternative to" target="GPL16372" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_UG v.13]" />
    <Relation type="Alternative to" target="GPL17392" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 17.1]" />
    <Relation type="Alternative to" target="GPL17394" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 13.0]" />
    <Relation type="Alternative to" target="GPL17810" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 16]" />
    <Relation type="Alternative to" target="GPL17811" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 17]" />
    <Relation type="Alternative to" target="GPL17996" comment="Alternative CDF:HGU133Plus2_Hs_ENTREZG.cdf version 15.1.0" />
    <Relation type="Alternative to" target="GPL18121" comment="custom CDF" />
    <Relation type="Alternative to: GPL18756 (Alternative CDF [CDF" target="HGU133Plus2_Hs_ENTREZG_14.1.0])" />
    <Relation type="Alternative to" target="GPL18850" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL18478" comment="Alternative CDF [Hs_ENTREZG_V13]" />
    <Relation type="Alternative to" target="GPL19109" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG_v18]" />
    <Relation type="Alternative to" target="GPL19883" comment="Alternative CDF [Broad GenePattern]" />
    <Relation type="Alternative to" target="GPL19918" comment="Gene symbol version, 10K" />
    <Relation type="Alternative to" target="GPL20182" comment="Gene Symbol Version" />
    <Relation type="Alternative to" target="GPL22321" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 20]" />
    <Relation type="Alternative to" target="GPL22945" comment="alternative" />
    <Relation type="Alternative to" target="GPL23270" comment="(Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 21]" />
    <Relation type="Alternative to" target="GPL23432" comment="alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray version 18.0.0]" />
    <Relation type="Alternative to" target="GPL25740" comment="alternative" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>Affymetrix Probe Set ID </Description>
        <Link-Prefix>https://www.affymetrix.com/LinkServlet?array=U133PLUS&amp;probeset=</Link-Prefix>
      </Column>
      <Column position="2">
        <Name>GB_ACC</Name>
        <Description>GenBank Accession Number </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
      </Column>
      <Column position="3">
        <Name>SPOT_ID</Name>
        <Description>identifies controls</Description>
      </Column>
      <Column position="4">
        <Name>Species Scientific Name</Name>
        <Description>The genus and species of the organism represented by the probe set.</Description>
      </Column>
      <Column position="5">
        <Name>Annotation Date</Name>
        <Description>The date that the annotations for this probe array were last updated. It will generally be earlier than the date when the annotations were posted on the Affymetrix web site.</Description>
      </Column>
      <Column position="6">
        <Name>Sequence Type</Name>
      </Column>
      <Column position="7">
        <Name>Sequence Source</Name>
        <Description>The database from which the sequence used to design this probe set was taken.</Description>
      </Column>
      <Column position="8">
        <Name>Target Description</Name>
      </Column>
      <Column position="9">
        <Name>Representative Public ID</Name>
        <Description>The accession number of a representative sequence. Note that for consensus-based probe sets, the representative sequence is only one of several sequences (sequence sub-clusters) used to build the consensus sequence and it is not directly used to derive the probe sequences. The representative sequence is chosen during array design as a sequence that is best associated with the transcribed region being interrogated by the probe set. Refer to the &quot;Sequence Source&quot; field to determine the database used.</Description>
      </Column>
      <Column position="10">
        <Name>Gene Title</Name>
        <Description>Title of Gene represented by the probe set.</Description>
      </Column>
      <Column position="11">
        <Name>Gene Symbol</Name>
        <Description>A gene symbol, when one is available (from UniGene).</Description>
      </Column>
      <Column position="12">
        <Name>ENTREZ_GENE_ID</Name>
        <Description>Entrez Gene Database UID  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/gene/</Link-Prefix>
        <Link-Delimiter> /// </Link-Delimiter>
      </Column>
      <Column position="13">
        <Name>RefSeq Transcript ID</Name>
        <Description>References to multiple sequences in RefSeq. The field contains the ID and Description for each entry, and there can be multiple entries per ProbeSet.</Description>
      </Column>
      <Column position="14">
        <Name>Gene Ontology Biological Process</Name>
        <Description>Gene Ontology Consortium Biological Process derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="15">
        <Name>Gene Ontology Cellular Component</Name>
        <Description>Gene Ontology Consortium Cellular Component derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="16">
        <Name>Gene Ontology Molecular Function</Name>
        <Description>Gene Ontology Consortium Molecular Function derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
    <External-Data rows="54675">
GPL570-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Platform iid="GPL6947">
    <Status database="GEO">
      <Submission-Date>2008-06-10</Submission-Date>
      <Release-Date>2008-06-10</Release-Date>
      <Last-Update-Date>2018-08-16</Last-Update-Date>
    </Status>
    <Title>Illumina HumanHT-12 V3.0 expression beadchip</Title>
    <Accession database="GEO">GPL6947</Accession>
    <Technology>oligonucleotide beads</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>Illumina Inc.</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's website
    </Manufacture-Protocol>
    <Description>
The HumanHT-12 V3.0 Expression BeadChip features up-to-date content derived from the National Center for Biotechnology Information Reference Sequence (NCBI RefSeq) database (Build 36.2, Release 22).

Please use the GEO Data Submission Report Plug-in v1.0 for Gene Expression which may be downloaded from https://icom.illumina.com/icom/software.ilmn?id=234 to format the normalized and raw data.  These should be submitted as part of a GEOarchive.  Instructions for assembling a GEOarchive may be found at http://www.ncbi.nlm.nih.gov/projects/geo/info/spreadsheet.html
    </Description>
    <Contact-Ref ref="contrib3" />
    <Supplementary-Data type="BGX">
ftp://ftp.ncbi.nlm.nih.gov/geo/platforms/GPL6nnn/GPL6947/suppl/GPL6947_HumanHT-12_V3_0_R1_11283641_A.bgx.gz
    </Supplementary-Data>
    <Relation type="Alternative to" target="GPL19915" comment="ILMN_GENE version" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>Unique identifier for the probe (across all products and species)</Description>
      </Column>
      <Column position="2">
        <Name>nuID</Name>
      </Column>
      <Column position="3">
        <Name>Species</Name>
      </Column>
      <Column position="4">
        <Name>Source</Name>
        <Description>Transcript sequence source name</Description>
      </Column>
      <Column position="5">
        <Name>Search_Key</Name>
        <Description>Internal id useful for custom design array</Description>
      </Column>
      <Column position="6">
        <Name>Transcript</Name>
        <Description>Internal transcript id</Description>
      </Column>
      <Column position="7">
        <Name>ILMN_Gene</Name>
        <Description>Internal gene symbol</Description>
      </Column>
      <Column position="8">
        <Name>Source_Reference_ID</Name>
        <Description>Id in the source database</Description>
      </Column>
      <Column position="9">
        <Name>RefSeq_ID</Name>
        <Description>Refseq id</Description>
      </Column>
      <Column position="10">
        <Name>Unigene_ID</Name>
        <Description>Unigene id</Description>
      </Column>
      <Column position="11">
        <Name>Entrez_Gene_ID</Name>
        <Description>Entrez gene id</Description>
      </Column>
      <Column position="12">
        <Name>GI</Name>
        <Description>Genbank id</Description>
      </Column>
      <Column position="13">
        <Name>Accession</Name>
        <Description>Genbank accession number</Description>
      </Column>
      <Column position="14">
        <Name>Symbol</Name>
        <Description>Gene symbol from the source database</Description>
      </Column>
      <Column position="15">
        <Name>Protein_Product</Name>
        <Description>Genbank protein accession number</Description>
      </Column>
      <Column position="16">
        <Name>Array_Address_Id</Name>
        <Description>Decoder id</Description>
      </Column>
      <Column position="17">
        <Name>Probe_Type</Name>
        <Description>Information about what this probe is targeting</Description>
      </Column>
      <Column position="18">
        <Name>Probe_Start</Name>
        <Description>Position of the probe relative to the 5' of the source transcript sequence</Description>
      </Column>
      <Column position="19">
        <Name>SEQUENCE</Name>
        <Description>Probe sequence</Description>
      </Column>
      <Column position="20">
        <Name>Chromosome</Name>
        <Description>Chromosome</Description>
      </Column>
      <Column position="21">
        <Name>Probe_Chr_Orientation</Name>
        <Description>Orientation on the NCBI genome built</Description>
      </Column>
      <Column position="22">
        <Name>Probe_Coordinates</Name>
        <Description>genomic position of the probe on the NCBI genome build 36 version 3</Description>
      </Column>
      <Column position="23">
        <Name>Cytoband</Name>
      </Column>
      <Column position="24">
        <Name>Definition</Name>
        <Description>Gene description from the source</Description>
      </Column>
      <Column position="25">
        <Name>Ontology_Component</Name>
        <Description>Cellular component annotations from Gene Ontology project</Description>
      </Column>
      <Column position="26">
        <Name>Ontology_Process</Name>
        <Description>Biological process annotations from Gene Ontology project</Description>
      </Column>
      <Column position="27">
        <Name>Ontology_Function</Name>
        <Description>Molecular function annotations from Gene Ontology project</Description>
      </Column>
      <Column position="28">
        <Name>Synonyms</Name>
        <Description>Gene symbol synonyms from Refseq</Description>
      </Column>
      <Column position="29">
        <Name>Obsolete_Probe_Id</Name>
        <Description>Identifier of probe id before bgx time</Description>
      </Column>
      <Column position="30">
        <Name>GB_ACC</Name>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
      </Column>
    <External-Data rows="49576">
GPL6947-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Platform iid="GPL13667">
    <Status database="GEO">
      <Submission-Date>2011-05-31</Submission-Date>
      <Release-Date>2011-05-31</Release-Date>
      <Last-Update-Date>2019-03-21</Last-Update-Date>
    </Status>
    <Title>[HG-U219] Affymetrix Human Genome U219 Array</Title>
    <Accession database="GEO">GPL13667</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's website
    </Manufacture-Protocol>
    <Relation type="Alternative to" target="GPL15803" comment="[Alternative ENSG Brainarray CDF Version 14.1.0]" />
    <Relation type="Alternative to" target="GPL18189" comment="Alternative CDF [HGU219_Hs_ENTREZG_15.1.0]" />
    <Relation type="Alternative to" target="GPL19099" comment="alternative" />
    <Relation type="Alternative to" target="GPL19100" comment="alternative" />
    <Relation type="Alternative to" target="GPL19211" comment="Alternative CDF [HGU219_Hs_ENSG_17.1.0]" />
    <Relation type="Alternative to" target="GPL19833" comment="Alternative CDF [HGU219_Hs_ENSG_18.0.0]" />
    <Relation type="Alternative to" target="GPL20650" comment="Alternative CDF [HG-U219_Hs_ENTREZG_18]" />
    <Relation type="Alternative to" target="GPL21464" comment="Alternative CDF [HGU219_Hs_ENTREZG_19.0.0]" />
    <Relation type="Alternative to" target="GPL24030" comment="Alternative CDF [HGU219_Hs_ENTREZG_20.0.0]" />
    <Relation type="Alternative to" target="GPL24052" comment="Alternative CDF" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>GeneChip Array</Name>
      </Column>
      <Column position="3">
        <Name>Species Scientific Name</Name>
      </Column>
      <Column position="4">
        <Name>Annotation Date</Name>
      </Column>
      <Column position="5">
        <Name>Sequence Type</Name>
      </Column>
      <Column position="6">
        <Name>Sequence Source</Name>
      </Column>
      <Column position="7">
        <Name>Transcript ID(Array Design)</Name>
      </Column>
      <Column position="8">
        <Name>Target Description</Name>
      </Column>
      <Column position="9">
        <Name>Representative Public ID</Name>
      </Column>
      <Column position="10">
        <Name>Archival UniGene Cluster</Name>
      </Column>
      <Column position="11">
        <Name>UniGene ID</Name>
      </Column>
      <Column position="12">
        <Name>Genome Version</Name>
      </Column>
      <Column position="13">
        <Name>Alignments</Name>
      </Column>
      <Column position="14">
        <Name>Gene Title</Name>
      </Column>
      <Column position="15">
        <Name>Gene Symbol</Name>
      </Column>
      <Column position="16">
        <Name>Chromosomal Location</Name>
      </Column>
      <Column position="17">
        <Name>GB_LIST</Name>
        <Description>GenBank accession numbers  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
        <Link-Delimiter>,</Link-Delimiter>
      </Column>
      <Column position="18">
        <Name>SPOT_ID</Name>
      </Column>
      <Column position="19">
        <Name>Unigene Cluster Type</Name>
      </Column>
      <Column position="20">
        <Name>Ensembl</Name>
      </Column>
      <Column position="21">
        <Name>Entrez Gene</Name>
      </Column>
      <Column position="22">
        <Name>SwissProt</Name>
      </Column>
      <Column position="23">
        <Name>EC</Name>
      </Column>
      <Column position="24">
        <Name>OMIM</Name>
      </Column>
      <Column position="25">
        <Name>RefSeq Protein ID</Name>
      </Column>
      <Column position="26">
        <Name>RefSeq Transcript ID</Name>
      </Column>
      <Column position="27">
        <Name>FlyBase</Name>
      </Column>
      <Column position="28">
        <Name>AGI</Name>
      </Column>
      <Column position="29">
        <Name>WormBase</Name>
      </Column>
      <Column position="30">
        <Name>MGI Name</Name>
      </Column>
      <Column position="31">
        <Name>RGD Name</Name>
      </Column>
      <Column position="32">
        <Name>SGD accession number</Name>
      </Column>
      <Column position="33">
        <Name>Gene Ontology Biological Process</Name>
      </Column>
      <Column position="34">
        <Name>Gene Ontology Cellular Component</Name>
      </Column>
      <Column position="35">
        <Name>Gene Ontology Molecular Function</Name>
      </Column>
      <Column position="36">
        <Name>Pathway</Name>
      </Column>
      <Column position="37">
        <Name>InterPro</Name>
      </Column>
      <Column position="38">
        <Name>Trans Membrane</Name>
      </Column>
      <Column position="39">
        <Name>QTL</Name>
      </Column>
      <Column position="40">
        <Name>Annotation Description</Name>
      </Column>
      <Column position="41">
        <Name>Annotation Transcript Cluster</Name>
      </Column>
      <Column position="42">
        <Name>Transcript Assignments</Name>
      </Column>
      <Column position="43">
        <Name>Annotation Notes</Name>
      </Column>
    <External-Data rows="49386">
GPL13667-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Platform iid="GPL15158">
    <Status database="GEO">
      <Submission-Date>2012-01-24</Submission-Date>
      <Release-Date>2013-01-11</Release-Date>
      <Last-Update-Date>2013-01-11</Last-Update-Date>
    </Status>
    <Title>Codelink 55K Human Array</Title>
    <Accession database="GEO">GPL15158</Accession>
    <Technology>spotted oligonucleotide</Technology>
    <Distribution>custom-commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>GE Healthcare</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's website
    </Manufacture-Protocol>
    <Contact-Ref ref="contrib4" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>GB_ACC</Name>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
      </Column>
      <Column position="3">
        <Name>Annotation_LocusLink</Name>
      </Column>
      <Column position="4">
        <Name>Annotation_NCBI_NID</Name>
      </Column>
      <Column position="5">
        <Name>Probe_type</Name>
      </Column>
      <Column position="6">
        <Name>Description</Name>
      </Column>
      <Column position="7">
        <Name>SPOT_ID</Name>
      </Column>
    <External-Data rows="53423">
GPL15158-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM627008">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con001</Title>
    <Accession database="GEO">GSM627008</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1715
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con001 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627008-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627009">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con017</Title>
    <Accession database="GEO">GSM627009</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3250
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con017 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627009-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627010">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con021</Title>
    <Accession database="GEO">GSM627010</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3440
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con021 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627010-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627011">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con022</Title>
    <Accession database="GEO">GSM627011</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2990
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con022 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627011-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627012">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con028</Title>
    <Accession database="GEO">GSM627012</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
36+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2370
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con028 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627012-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627013">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con029</Title>
    <Accession database="GEO">GSM627013</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2940
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con029 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627013-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627014">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con040</Title>
    <Accession database="GEO">GSM627014</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2800
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con040 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627014-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627015">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con042</Title>
    <Accession database="GEO">GSM627015</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
umbilical swab grew anaerobes, coliforms, Saureus and gp B strep
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3980
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con042 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627015-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627016">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con043</Title>
    <Accession database="GEO">GSM627016</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3980
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con043 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627016-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627017">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con046</Title>
    <Accession database="GEO">GSM627017</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3500
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con046 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627017-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627018">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con048</Title>
    <Accession database="GEO">GSM627018</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4590
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con048 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627018-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627019">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con049</Title>
    <Accession database="GEO">GSM627019</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4140
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con049 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627019-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627020">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con051</Title>
    <Accession database="GEO">GSM627020</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3020
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con051 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627020-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627021">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con058</Title>
    <Accession database="GEO">GSM627021</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4120
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con058 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627021-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627022">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con062</Title>
    <Accession database="GEO">GSM627022</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
no. blood culture 3 days previously negative
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4270
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con062 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627022-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627023">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con063</Title>
    <Accession database="GEO">GSM627023</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
44+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3309
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con063 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627023-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627024">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con065</Title>
    <Accession database="GEO">GSM627024</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3620
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con065 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627024-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627025">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con067</Title>
    <Accession database="GEO">GSM627025</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+4
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2225
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con067 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627025-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627026">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con069</Title>
    <Accession database="GEO">GSM627026</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3510
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con069 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627026-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627027">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con071</Title>
    <Accession database="GEO">GSM627027</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4300
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con071 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627027-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627028">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con072</Title>
    <Accession database="GEO">GSM627028</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4370
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con072 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627028-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627029">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con073</Title>
    <Accession database="GEO">GSM627029</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
well. 3 days later had Saureus in wound swab.
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1880
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con073 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627029-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627030">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con077</Title>
    <Accession database="GEO">GSM627030</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3630
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con077 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627030-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627031">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con079</Title>
    <Accession database="GEO">GSM627031</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3440
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con079 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627031-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627032">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con081</Title>
    <Accession database="GEO">GSM627032</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+4
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3500
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con081 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627032-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627033">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con086</Title>
    <Accession database="GEO">GSM627033</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
43+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con086 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627033-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627034">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con087</Title>
    <Accession database="GEO">GSM627034</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2200
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con087 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627034-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627035">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con096</Title>
    <Accession database="GEO">GSM627035</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3700
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con096 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627035-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627036">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con097</Title>
    <Accession database="GEO">GSM627036</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4301
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con097 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627036-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627037">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con165</Title>
    <Accession database="GEO">GSM627037</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
930
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con165 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627037-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627038">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con181</Title>
    <Accession database="GEO">GSM627038</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
33+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
670
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con181 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627038-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627039">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con200</Title>
    <Accession database="GEO">GSM627039</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1115
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con200 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627039-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627040">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con202</Title>
    <Accession database="GEO">GSM627040</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1600
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con202 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627040-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627041">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con206</Title>
    <Accession database="GEO">GSM627041</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
32+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1225
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con206 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627041-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627042">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con207</Title>
    <Accession database="GEO">GSM627042</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4200
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Con207 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627042-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627043">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf009</Title>
    <Accession database="GEO">GSM627043</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
coag neg staph long line tip next day, previous ureaplasma,,no previous positive blood cultures
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
32+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
720
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf009 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627043-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627044">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf047</Title>
    <Accession database="GEO">GSM627044</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
control
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
candida
      </Characteristics>
      <Characteristics tag="other positive results">
klebsiella in peritoneal fluid and ET secretions, NEC 1 week previously, candida in blood 4 days previously
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1380
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf047 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627044-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627045">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf075</Title>
    <Accession database="GEO">GSM627045</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
CMV in blood and urine
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
36+4
      </Characteristics>
      <Characteristics tag="birthweight (g)">
890
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
Corrected_gestational_age_(weeks+days):36+4
Birthweight_(g):890
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf075 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627045-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627046">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf082</Title>
    <Accession database="GEO">GSM627046</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive (enterobacter cloacae)
      </Characteristics>
      <Characteristics tag="other positive results">
enterobacter cloacae (also 1 week post sample)
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1230
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf082 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627046-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627047">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf083</Title>
    <Accession database="GEO">GSM627047</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (E faecium)
      </Characteristics>
      <Characteristics tag="other positive results">
Blood cultures 3 days before and 2 days after also E faecium
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1405
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf083 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627047-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627048">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf084</Title>
    <Accession database="GEO">GSM627048</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF coag neg staph.  Also from day before long line tip and BC grew coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
720
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf084 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627048-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627049">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf089</Title>
    <Accession database="GEO">GSM627049</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF and urine negative
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
28+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
850
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf089 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627049-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627050">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf091</Title>
    <Accession database="GEO">GSM627050</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (Group B Strep)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF negative
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
38+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3900
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf091 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627050-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627051">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf102</Title>
    <Accession database="GEO">GSM627051</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (pseudomonas aeuruginosa and coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
Blood culture positive for pseudomonas and coag neg staph, coag neg staph also present in blood cultures x 2 in previous week and also the next day
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
785
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf102 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627051-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627052">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf111</Title>
    <Accession database="GEO">GSM627052</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
2 blood cultures coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1200
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf111 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627052-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627053">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf112</Title>
    <Accession database="GEO">GSM627053</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive(group B strep)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
25+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
660
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf112 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627053-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627054">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf114</Title>
    <Accession database="GEO">GSM627054</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
long line tip coag neg staph, previous day ETT tip and ETS Ecoli/coliforms
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
955
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf114 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627054-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627055">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf116</Title>
    <Accession database="GEO">GSM627055</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
aspirate of abscess grew coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
720
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf116 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627055-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627056">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf119</Title>
    <Accession database="GEO">GSM627056</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
983
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf119 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627056-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627057">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf125</Title>
    <Accession database="GEO">GSM627057</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Postive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 5 days previous grew coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
983
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf125 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627057-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627058">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf132</Title>
    <Accession database="GEO">GSM627058</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (E faecalis)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 2 and 4 days previously and next day also enterococcus
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1100
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf132 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627058-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627059">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf133</Title>
    <Accession database="GEO">GSM627059</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+4
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1140
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf133 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627059-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627060">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf138</Title>
    <Accession database="GEO">GSM627060</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
870
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf138 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627060-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627061">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf145</Title>
    <Accession database="GEO">GSM627061</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Enterococcus faecalis
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
28+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1100
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf145 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627061-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627062">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf149</Title>
    <Accession database="GEO">GSM627062</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
1cfu Klebsiells in CSF
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
840
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf149 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627062-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627063">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf152</Title>
    <Accession database="GEO">GSM627063</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 3 days previous 2 strains coag neg staph, line tip 2 days previous mixed coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
450
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf152 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627063-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627064">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf157</Title>
    <Accession database="GEO">GSM627064</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+3
      </Characteristics>
      <Characteristics tag="birthweight (g)">
820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf157 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627064-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627065">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf159</Title>
    <Accession database="GEO">GSM627065</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(enterococcus)
      </Characteristics>
      <Characteristics tag="other positive results">
csf 1 no growth, 2 coag neg staph
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+2
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1335
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf159 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627065-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627066">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf162</Title>
    <Accession database="GEO">GSM627066</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
2 separate blood cultures coag neg staph, csf no growth
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+6
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1130
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf162 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627066-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627067">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf164</Title>
    <Accession database="GEO">GSM627067</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(kelbsiella oxytoca)
      </Characteristics>
      <Characteristics tag="other positive results">
not stated
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+5
      </Characteristics>
      <Characteristics tag="birthweight (g)">
820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf164 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627067-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627068">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf191</Title>
    <Accession database="GEO">GSM627068</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(E coli)
      </Characteristics>
      <Characteristics tag="other positive results">
csf no growth
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2970
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf191 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627068-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627069">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf198</Title>
    <Accession database="GEO">GSM627069</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
csf no growth, note CoNeg Staph resistant to fluclox and gent which baby on further deterioration and repeat sample thoughâ¦
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
33+1
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1070
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf198 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627069-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM627070">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf203</Title>
    <Accession database="GEO">GSM627070</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="neonate">
infected
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase negative staphylococcus
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1070
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Illumina hybridization protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Standard Illumina scanning protocol
    </Scan-Protocol>
    <Description>
set:Training Set
    </Description>
    <Data-Processing>
Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.
    </Data-Processing>
    <Platform-Ref ref="GPL6947" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="unknown">
NONE
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Robust spline normalised data output from the lumi package of Bioconductor.</Description>
      </Column>
      <Column position="3">
        <Name>Inf203 Detection Pval</Name>
      </Column>
    <External-Data rows="23292">
GSM627070-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404208">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con006</Title>
    <Accession database="GEO">GSM1404208</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4240
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404208/suppl/GSM1404208_CSB006.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="54675">
GSM1404208-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404209">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con014</Title>
    <Accession database="GEO">GSM1404209</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
38+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2970
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404209/suppl/GSM1404209_CSB014.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="54675">
GSM1404209-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404210">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con030</Title>
    <Accession database="GEO">GSM1404210</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
umbilical swab grew proteus (may represent colonisation)
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3270
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404210/suppl/GSM1404210_CSB030.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="54675">
GSM1404210-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404211">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf012</Title>
    <Accession database="GEO">GSM1404211</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
CSF: enterovirus on PCR.  CSF also grew coag neg staph, CSF WCC 300, RBC 9
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2150
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404211/suppl/GSM1404211_CSB012.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="54675">
GSM1404211-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404212">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf032</Title>
    <Accession database="GEO">GSM1404212</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
yes CSF grew Listeria monocytogenes, CSF white cell count 551, RBC 119, urine no growth
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3180
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404212/suppl/GSM1404212_CSB032.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="54675">
GSM1404212-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404213">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con209</Title>
    <Accession database="GEO">GSM1404213</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
37+4
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1120
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404213/suppl/GSM1404213_Con209.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404213-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404214">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con213</Title>
    <Accession database="GEO">GSM1404214</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
30+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
890
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404214/suppl/GSM1404214_Con213.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404214-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404215">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con220</Title>
    <Accession database="GEO">GSM1404215</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
34+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1515
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404215/suppl/GSM1404215_Con220.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404215-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404216">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con260</Title>
    <Accession database="GEO">GSM1404216</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
29+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404216/suppl/GSM1404216_Con260.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404216-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404217">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con270</Title>
    <Accession database="GEO">GSM1404217</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
32+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1875
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404217/suppl/GSM1404217_Con270.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404217-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404218">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con293</Title>
    <Accession database="GEO">GSM1404218</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
29+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="birthweight (g)">
855
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404218/suppl/GSM1404218_Con293.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404218-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404219">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf216</Title>
    <Accession database="GEO">GSM1404219</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
34+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Enterococcus
      </Characteristics>
      <Characteristics tag="birthweight (g)">
810
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404219/suppl/GSM1404219_Inf216.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404219-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404220">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf226</Title>
    <Accession database="GEO">GSM1404220</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
33+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Enterococcus &amp; Staph. warneri
      </Characteristics>
      <Characteristics tag="other positive results">
BC next day grew Staphylococcus warneri
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1385
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404220/suppl/GSM1404220_Inf226.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404220-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404221">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf239</Title>
    <Accession database="GEO">GSM1404221</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
27+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Pseudomonas aeruginosa &amp; Coagulase -ve Staph. aureus
      </Characteristics>
      <Characteristics tag="other positive results">
Next day, peritoneal swab enterococcus, pseudomonas aeruginosa and klebsiella oxytoca
      </Characteristics>
      <Characteristics tag="birthweight (g)">
680
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404221/suppl/GSM1404221_Inf239.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404221-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404222">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf262</Title>
    <Accession database="GEO">GSM1404222</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
39+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Group B Strep.
      </Characteristics>
      <Characteristics tag="birthweight (g)">
690
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404222/suppl/GSM1404222_Inf262.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404222-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404223">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf271</Title>
    <Accession database="GEO">GSM1404223</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
35+6
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Staph. epidermidis
      </Characteristics>
      <Characteristics tag="other positive results">
grew yeasts 2 days later
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1040
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404223/suppl/GSM1404223_Inf271.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404223-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404224">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf275</Title>
    <Accession database="GEO">GSM1404224</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
39+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase -ve Staph. aureus
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1255
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404224/suppl/GSM1404224_Inf275.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404224-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404225">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf287</Title>
    <Accession database="GEO">GSM1404225</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
34+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
E. coli
      </Characteristics>
      <Characteristics tag="birthweight (g)">
880
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404225/suppl/GSM1404225_Inf287.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404225-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404226">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf297</Title>
    <Accession database="GEO">GSM1404226</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
35+4
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Serratia marcescens
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1490
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404226/suppl/GSM1404226_Inf297.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404226-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404227">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf299</Title>
    <Accession database="GEO">GSM1404227</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
36+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Serratia marcescens
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1490
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404227/suppl/GSM1404227_Inf299.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404227-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404228">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>NEC253</Title>
    <Accession database="GEO">GSM1404228</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
36+2
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="other positive results">
Coagulase -ve Staph. aureus previous day
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1390
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404228/suppl/GSM1404228_NEC253.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404228-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404229">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>NEC283</Title>
    <Accession database="GEO">GSM1404229</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
31+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="other positive results">
Enterobacter cloacae, 6 days previously
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1490
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404229/suppl/GSM1404229_NEC283.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404229-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404230">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Vir228</Title>
    <Accession database="GEO">GSM1404230</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
34+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="other positive results">
Rhinovirus PCR +ve
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1920
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404230/suppl/GSM1404230_Vir228.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404230-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404231">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Vir269</Title>
    <Accession database="GEO">GSM1404231</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
35+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
CMV
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1290
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404231/suppl/GSM1404231_Vir269.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404231-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404232">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Vir278</Title>
    <Accession database="GEO">GSM1404232</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age at sample (weeks+days)">
32+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
n/a
      </Characteristics>
      <Characteristics tag="other positive results">
Rhinovirus PCR +ve
      </Characteristics>
      <Characteristics tag="birthweight (g)">
855
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.
    </Hybridization-Protocol>
    <Scan-Protocol>
GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.
    </Data-Processing>
    <Platform-Ref ref="GPL13667" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404232/suppl/GSM1404232_Vir278.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>log2 RMA signal</Description>
      </Column>
    <External-Data rows="49386">
GSM1404232-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404233">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con001</Title>
    <Accession database="GEO">GSM1404233</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+6
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1715
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404233/suppl/GSM1404233_Con001.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404233-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404234">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con017</Title>
    <Accession database="GEO">GSM1404234</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+6
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3250
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404234/suppl/GSM1404234_Con017.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404234-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404235">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con028</Title>
    <Accession database="GEO">GSM1404235</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
36+5
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2370
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404235/suppl/GSM1404235_Con028.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404235-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404236">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con042</Title>
    <Accession database="GEO">GSM1404236</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
umbilical swab grew anaerobes, coliforms, Saureus and gp B strep
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3980
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404236/suppl/GSM1404236_Con042.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404236-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404237">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con049</Title>
    <Accession database="GEO">GSM1404237</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+5
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4140
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404237/suppl/GSM1404237_Con049.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404237-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404238">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con051</Title>
    <Accession database="GEO">GSM1404238</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3020
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404238/suppl/GSM1404238_Con051.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404238-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404239">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con058</Title>
    <Accession database="GEO">GSM1404239</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4120
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404239/suppl/GSM1404239_Con058.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404239-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404240">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con062</Title>
    <Accession database="GEO">GSM1404240</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
no. blood culture 3 days previously negative
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4270
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404240/suppl/GSM1404240_Con062.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404240-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404241">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con063</Title>
    <Accession database="GEO">GSM1404241</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
44+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3309
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404241/suppl/GSM1404241_Con063.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404241-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404242">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con065</Title>
    <Accession database="GEO">GSM1404242</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3620
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404242/suppl/GSM1404242_Con065.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404242-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404243">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con067</Title>
    <Accession database="GEO">GSM1404243</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
39+4
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2225
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404243/suppl/GSM1404243_Con067.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404243-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404244">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con069</Title>
    <Accession database="GEO">GSM1404244</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3510
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404244/suppl/GSM1404244_Con069.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404244-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404245">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con071</Title>
    <Accession database="GEO">GSM1404245</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
42+6
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4300
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404245/suppl/GSM1404245_Con071.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404245-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404246">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con072</Title>
    <Accession database="GEO">GSM1404246</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4370
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404246/suppl/GSM1404246_Con072.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404246-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404247">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con073</Title>
    <Accession database="GEO">GSM1404247</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
well. 3 days later had Saureus in wound swab.
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1880
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404247/suppl/GSM1404247_Con073.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404247-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404248">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con079</Title>
    <Accession database="GEO">GSM1404248</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3440
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404248/suppl/GSM1404248_Con079.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404248-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404249">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con081</Title>
    <Accession database="GEO">GSM1404249</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+4
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3500
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404249/suppl/GSM1404249_Con081.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404249-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404250">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con086</Title>
    <Accession database="GEO">GSM1404250</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
43+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404250/suppl/GSM1404250_Con086.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404250-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404251">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con087</Title>
    <Accession database="GEO">GSM1404251</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+2
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2200
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404251/suppl/GSM1404251_Con087.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404251-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404252">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con096</Title>
    <Accession database="GEO">GSM1404252</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3700
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404252/suppl/GSM1404252_Con096.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404252-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404253">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con165</Title>
    <Accession database="GEO">GSM1404253</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
930
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404253/suppl/GSM1404253_Con165.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404253-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404254">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con181</Title>
    <Accession database="GEO">GSM1404254</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
33+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
670
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404254/suppl/GSM1404254_Con181.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404254-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404255">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con200</Title>
    <Accession database="GEO">GSM1404255</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1115
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404255/suppl/GSM1404255_Con200.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404255-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404256">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con202</Title>
    <Accession database="GEO">GSM1404256</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1600
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404256/suppl/GSM1404256_Con202.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404256-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404257">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf047</Title>
    <Accession database="GEO">GSM1404257</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
candida
      </Characteristics>
      <Characteristics tag="other positive results">
klebsiella in peritoneal fluid and ET secretions, NEC 1 week previously, candida in blood 4 days previously
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1380
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404257/suppl/GSM1404257_Inf047.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404257-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404258">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf082</Title>
    <Accession database="GEO">GSM1404258</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive (enterobacter cloacae)
      </Characteristics>
      <Characteristics tag="other positive results">
enterobacter cloacae (also 1 week post sample)
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1230
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404258/suppl/GSM1404258_Inf082.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404258-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404259">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf083</Title>
    <Accession database="GEO">GSM1404259</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (E faecium)
      </Characteristics>
      <Characteristics tag="other positive results">
Blood cultures 3 days before and 2 days after also E faecium
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1405
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404259/suppl/GSM1404259_Inf083.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404259-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404260">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf084</Title>
    <Accession database="GEO">GSM1404260</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF coag neg staph.  Also from day before long line tip and BC grew coag neg staph
      </Characteristics>
      <Characteristics tag="birthweight (g)">
720
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404260/suppl/GSM1404260_Inf084.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404260-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404261">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf089</Title>
    <Accession database="GEO">GSM1404261</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
28+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF and urine negative
      </Characteristics>
      <Characteristics tag="birthweight (g)">
850
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404261/suppl/GSM1404261_Inf089.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404261-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404262">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf091</Title>
    <Accession database="GEO">GSM1404262</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
38+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (Group B Strep)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF negative
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3900
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404262/suppl/GSM1404262_Inf091.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404262-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404263">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf102</Title>
    <Accession database="GEO">GSM1404263</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (pseudomonas aeuruginosa and coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
Blood culture positive for pseudomonas and coag neg staph, coag neg staph also present in blood cultures x 2 in previous week and also the next day
      </Characteristics>
      <Characteristics tag="birthweight (g)">
785
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404263/suppl/GSM1404263_Inf102.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404263-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404264">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf112</Title>
    <Accession database="GEO">GSM1404264</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
25+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive(group B strep)
      </Characteristics>
      <Characteristics tag="other positive results">
CSF coag neg staph
      </Characteristics>
      <Characteristics tag="birthweight (g)">
660
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404264/suppl/GSM1404264_inf112.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404264-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404265">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf114</Title>
    <Accession database="GEO">GSM1404265</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+2
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
long line tip coag neg staph, previous day ETT tip and ETS Ecoli/coliforms
      </Characteristics>
      <Characteristics tag="birthweight (g)">
955
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404265/suppl/GSM1404265_Inf114.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404265-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404266">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf125</Title>
    <Accession database="GEO">GSM1404266</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+5
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Postive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 5 days previous grew coag neg staph
      </Characteristics>
      <Characteristics tag="birthweight (g)">
983
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404266/suppl/GSM1404266_Inf125.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404266-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404267">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf132</Title>
    <Accession database="GEO">GSM1404267</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (E faecalis)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 2 and 4 days previously and next day also enterococcus
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1100
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404267/suppl/GSM1404267_Inf132.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404267-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404268">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf138</Title>
    <Accession database="GEO">GSM1404268</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+2
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Positive (coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
No
      </Characteristics>
      <Characteristics tag="birthweight (g)">
870
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404268/suppl/GSM1404268_Inf138.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404268-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404269">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf152</Title>
    <Accession database="GEO">GSM1404269</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
blood culture 3 days previous 2 strains coag neg staph, line tip 2 days previous mixed coag neg staph
      </Characteristics>
      <Characteristics tag="birthweight (g)">
450
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404269/suppl/GSM1404269_Inf152.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404269-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404270">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf159</Title>
    <Accession database="GEO">GSM1404270</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(enterococcus)
      </Characteristics>
      <Characteristics tag="other positive results">
csf 1 no growth, 2 coag neg staph
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1335
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404270/suppl/GSM1404270_Inf159.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404270-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404271">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf162</Title>
    <Accession database="GEO">GSM1404271</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
27+6
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
2 separate blood cultures coag neg staph, csf no growth
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1130
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404271/suppl/GSM1404271_Inf162.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404271-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404272">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf164</Title>
    <Accession database="GEO">GSM1404272</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+5
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(kelbsiella oxytoca)
      </Characteristics>
      <Characteristics tag="other positive results">
not stated
      </Characteristics>
      <Characteristics tag="birthweight (g)">
820
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404272/suppl/GSM1404272_Inf164.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404272-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404273">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf191</Title>
    <Accession database="GEO">GSM1404273</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(E coli)
      </Characteristics>
      <Characteristics tag="other positive results">
csf no growth
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2970
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404273/suppl/GSM1404273_Inf191.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404273-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404274">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf198</Title>
    <Accession database="GEO">GSM1404274</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
33+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
positive(coag neg staph)
      </Characteristics>
      <Characteristics tag="other positive results">
csf no growth, note CoNeg Staph resistant to fluclox and gent which baby on further deterioration and repeat sample thoughâ¦
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1070
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Platform Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404274/suppl/GSM1404274_Inf198.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404274-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404275">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con006</Title>
    <Accession database="GEO">GSM1404275</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4240
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404275/suppl/GSM1404275_Con006.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404275-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404276">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con014</Title>
    <Accession database="GEO">GSM1404276</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
38+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2970
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404276/suppl/GSM1404276_Con014.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404276-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404277">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Con179</Title>
    <Accession database="GEO">GSM1404277</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
na
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1960
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404277/suppl/GSM1404277_Con179.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404277-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404278">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf012</Title>
    <Accession database="GEO">GSM1404278</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+6
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
CSF: enterovirus on PCR.  CSF also grew coag neg staph, CSF WCC 300, RBC 9
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2150
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404278/suppl/GSM1404278_Inf012.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404278-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404279">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf032</Title>
    <Accession database="GEO">GSM1404279</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
yes CSF grew Listeria monocytogenes, CSF white cell count 551, RBC 119, urine no growth
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3180
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404279/suppl/GSM1404279_Inf032.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404279-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404280">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf107</Title>
    <Accession database="GEO">GSM1404280</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
24+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase -ve Staph. Aureus
      </Characteristics>
      <Characteristics tag="other positive results">
BC next day also coag neg staph and line tip 2 days later.  ETS refer back to sample from 2 days previous where positive for ureaplasma and mycoplasma.
      </Characteristics>
      <Characteristics tag="birthweight (g)">
655
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404280/suppl/GSM1404280_inf107.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404280-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404281">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf118</Title>
    <Accession database="GEO">GSM1404281</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+3
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase -ve Staph. Aureus
      </Characteristics>
      <Characteristics tag="other positive results">
CSF negative
      </Characteristics>
      <Characteristics tag="birthweight (g)">
940
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404281/suppl/GSM1404281_Inf118.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404281-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404282">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf137</Title>
    <Accession database="GEO">GSM1404282</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
Yes
      </Characteristics>
      <Characteristics tag="bloodculture result">
Coagulase -ve Staph. Aureus
      </Characteristics>
      <Characteristics tag="other positive results">
long line tip also coag neg staph, coag neg staph from blood culture 6 days previously
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1150
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404282/suppl/GSM1404282_Inf137.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404282-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404283">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf155</Title>
    <Accession database="GEO">GSM1404283</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
28+3
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Klebsiella pneumoniae
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
840
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404283/suppl/GSM1404283_Inf155.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404283-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404284">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Inf161</Title>
    <Accession database="GEO">GSM1404284</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+2
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
Klebsiella oxytoca
      </Characteristics>
      <Characteristics tag="other positive results">
csf klebsiella oxytoca but blood stained
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1090
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Validation Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404284/suppl/GSM1404284_Inf161.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404284-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404285">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus002</Title>
    <Accession database="GEO">GSM1404285</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3480
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404285/suppl/GSM1404285_Sus002.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404285-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404286">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus005</Title>
    <Accession database="GEO">GSM1404286</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+5
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
750
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404286/suppl/GSM1404286_Sus005.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404286-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404287">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus008</Title>
    <Accession database="GEO">GSM1404287</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
33+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1370
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404287/suppl/GSM1404287_Sus008.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404287-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404288">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus010</Title>
    <Accession database="GEO">GSM1404288</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
38+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3660
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404288/suppl/GSM1404288_Sus010.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404288-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404289">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus011</Title>
    <Accession database="GEO">GSM1404289</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
right eye swab coag neg staph (likely colonisation), csf negative
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2510
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404289/suppl/GSM1404289_Sus011.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404289-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404290">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus013</Title>
    <Accession database="GEO">GSM1404290</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3530
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404290/suppl/GSM1404290_Sus013.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404290-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404291">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus019</Title>
    <Accession database="GEO">GSM1404291</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1510
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404291/suppl/GSM1404291_Sus019.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404291-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404292">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus020</Title>
    <Accession database="GEO">GSM1404292</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1930
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404292/suppl/GSM1404292_Sus020.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404292-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404293">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus024</Title>
    <Accession database="GEO">GSM1404293</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2170
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404293/suppl/GSM1404293_Sus024.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404293-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404294">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus025</Title>
    <Accession database="GEO">GSM1404294</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2210
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404294/suppl/GSM1404294_Sus025.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404294-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404295">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus026</Title>
    <Accession database="GEO">GSM1404295</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2725
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404295/suppl/GSM1404295_Sus026.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404295-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404296">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus027</Title>
    <Accession database="GEO">GSM1404296</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3615
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404296/suppl/GSM1404296_Sus027.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404296-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404297">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus033</Title>
    <Accession database="GEO">GSM1404297</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1840
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404297/suppl/GSM1404297_Sus033.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404297-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404298">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus034</Title>
    <Accession database="GEO">GSM1404298</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no, 2 days later had serratia marcesens in ET secretions
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1490
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404298/suppl/GSM1404298_Sus034.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404298-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404299">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus035</Title>
    <Accession database="GEO">GSM1404299</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4860
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404299/suppl/GSM1404299_Sus035.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404299-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404300">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus036</Title>
    <Accession database="GEO">GSM1404300</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3360
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404300/suppl/GSM1404300_Sus036.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404300-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404301">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus037</Title>
    <Accession database="GEO">GSM1404301</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
30+4
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
over previous 5 days had coliforms and S.aureus in NP/ET secretions
      </Characteristics>
      <Characteristics tag="birthweight (g)">
700
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404301/suppl/GSM1404301_Sus037.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404301-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404302">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus038</Title>
    <Accession database="GEO">GSM1404302</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1130
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404302/suppl/GSM1404302_Sus038.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404302-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404303">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus039</Title>
    <Accession database="GEO">GSM1404303</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1345
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404303/suppl/GSM1404303_Sus039.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404303-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404304">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus041</Title>
    <Accession database="GEO">GSM1404304</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
29+4
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1750
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404304/suppl/GSM1404304_Sus041.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404304-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404305">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus044</Title>
    <Accession database="GEO">GSM1404305</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
36+0
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2550
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404305/suppl/GSM1404305_Sus044.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404305-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404306">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus053</Title>
    <Accession database="GEO">GSM1404306</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
35+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2230
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404306/suppl/GSM1404306_Sus053.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404306-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404307">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus054</Title>
    <Accession database="GEO">GSM1404307</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3080
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404307/suppl/GSM1404307_Sus054.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404307-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404308">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus055</Title>
    <Accession database="GEO">GSM1404308</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
4520
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404308/suppl/GSM1404308_Sus055.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404308-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404309">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus057</Title>
    <Accession database="GEO">GSM1404309</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
37+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2985
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404309/suppl/GSM1404309_Sus057.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404309-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404310">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus059</Title>
    <Accession database="GEO">GSM1404310</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
41+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3600
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404310/suppl/GSM1404310_Sus059.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404310-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404311">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus061</Title>
    <Accession database="GEO">GSM1404311</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
31+2
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
1210
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404311/suppl/GSM1404311_Sus061.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404311-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404312">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus064</Title>
    <Accession database="GEO">GSM1404312</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
26+4
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
ET tip and eye swabs positive for Ecoli
      </Characteristics>
      <Characteristics tag="birthweight (g)">
970
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404312/suppl/GSM1404312_Sus064.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404312-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404313">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus068</Title>
    <Accession database="GEO">GSM1404313</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
40+1
      </Characteristics>
      <Characteristics tag="gender">
Male
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
3680
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404313/suppl/GSM1404313_Sus068.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404313-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1404314">
    <Status database="GEO">
      <Submission-Date>2014-06-04</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2016-06-14</Last-Update-Date>
    </Status>
    <Title>Sus074</Title>
    <Accession database="GEO">GSM1404314</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>peripheral blood</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
peripheral blood
      </Characteristics>
      <Characteristics tag="corrected gestational age (weeks+days)">
34+0
      </Characteristics>
      <Characteristics tag="gender">
Female
      </Characteristics>
      <Characteristics tag="on antibiotics at time of sample">
No
      </Characteristics>
      <Characteristics tag="bloodculture result">
negative
      </Characteristics>
      <Characteristics tag="other positive results">
no
      </Characteristics>
      <Characteristics tag="birthweight (g)">
2220
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html )
    </Hybridization-Protocol>
    <Scan-Protocol>
The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).
    </Scan-Protocol>
    <Description>
Suspected Infected Test Set
    </Description>
    <Data-Processing>
Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.
    </Data-Processing>
    <Platform-Ref ref="GPL15158" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1404nnn/GSM1404314/suppl/GSM1404314_Sus074.TXT.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA signal</Description>
      </Column>
    <External-Data rows="53423">
GSM1404314-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE25504">
    <Status database="GEO">
      <Submission-Date>2010-11-19</Submission-Date>
      <Release-Date>2014-08-12</Release-Date>
      <Last-Update-Date>2019-03-25</Last-Update-Date>
    </Status>
    <Title>Whole blood mRNA expression profiling of host molecular networks in neonatal sepsis</Title>
    <Accession database="GEO">GSE25504</Accession>
    <Pubmed-ID>25120092</Pubmed-ID>
    <Pubmed-ID>26484146</Pubmed-ID>
    <Summary>
We aimed to identify the gene network and pathway biology associated with neonatal sepsis by determining genome-wide alterations in host RNA in infected infants
    </Summary>
    <Overall-Design>
Samples were obtained from control and infected human neonates.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib5" position="1" />
    <Contributor-Ref ref="contrib6" position="2" />
    <Contributor-Ref ref="contrib7" position="3" />
    <Contributor-Ref ref="contrib8" position="4" />
    <Contributor-Ref ref="contrib9" position="5" />
    <Contributor-Ref ref="contrib10" position="6" />
    <Contributor-Ref ref="contrib11" position="7" />
    <Contributor-Ref ref="contrib12" position="8" />
    <Contributor-Ref ref="contrib13" position="9" />
    <Contributor-Ref ref="contrib14" position="10" />
    <Contributor-Ref ref="contrib15" position="11" />
    <Contributor-Ref ref="contrib16" position="12" />
    <Contributor-Ref ref="contrib1" position="13" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM627008" />
    <Sample-Ref ref="GSM627009" />
    <Sample-Ref ref="GSM627010" />
    <Sample-Ref ref="GSM627011" />
    <Sample-Ref ref="GSM627012" />
    <Sample-Ref ref="GSM627013" />
    <Sample-Ref ref="GSM627014" />
    <Sample-Ref ref="GSM627015" />
    <Sample-Ref ref="GSM627016" />
    <Sample-Ref ref="GSM627017" />
    <Sample-Ref ref="GSM627018" />
    <Sample-Ref ref="GSM627019" />
    <Sample-Ref ref="GSM627020" />
    <Sample-Ref ref="GSM627021" />
    <Sample-Ref ref="GSM627022" />
    <Sample-Ref ref="GSM627023" />
    <Sample-Ref ref="GSM627024" />
    <Sample-Ref ref="GSM627025" />
    <Sample-Ref ref="GSM627026" />
    <Sample-Ref ref="GSM627027" />
    <Sample-Ref ref="GSM627028" />
    <Sample-Ref ref="GSM627029" />
    <Sample-Ref ref="GSM627030" />
    <Sample-Ref ref="GSM627031" />
    <Sample-Ref ref="GSM627032" />
    <Sample-Ref ref="GSM627033" />
    <Sample-Ref ref="GSM627034" />
    <Sample-Ref ref="GSM627035" />
    <Sample-Ref ref="GSM627036" />
    <Sample-Ref ref="GSM627037" />
    <Sample-Ref ref="GSM627038" />
    <Sample-Ref ref="GSM627039" />
    <Sample-Ref ref="GSM627040" />
    <Sample-Ref ref="GSM627041" />
    <Sample-Ref ref="GSM627042" />
    <Sample-Ref ref="GSM627043" />
    <Sample-Ref ref="GSM627044" />
    <Sample-Ref ref="GSM627045" />
    <Sample-Ref ref="GSM627046" />
    <Sample-Ref ref="GSM627047" />
    <Sample-Ref ref="GSM627048" />
    <Sample-Ref ref="GSM627049" />
    <Sample-Ref ref="GSM627050" />
    <Sample-Ref ref="GSM627051" />
    <Sample-Ref ref="GSM627052" />
    <Sample-Ref ref="GSM627053" />
    <Sample-Ref ref="GSM627054" />
    <Sample-Ref ref="GSM627055" />
    <Sample-Ref ref="GSM627056" />
    <Sample-Ref ref="GSM627057" />
    <Sample-Ref ref="GSM627058" />
    <Sample-Ref ref="GSM627059" />
    <Sample-Ref ref="GSM627060" />
    <Sample-Ref ref="GSM627061" />
    <Sample-Ref ref="GSM627062" />
    <Sample-Ref ref="GSM627063" />
    <Sample-Ref ref="GSM627064" />
    <Sample-Ref ref="GSM627065" />
    <Sample-Ref ref="GSM627066" />
    <Sample-Ref ref="GSM627067" />
    <Sample-Ref ref="GSM627068" />
    <Sample-Ref ref="GSM627069" />
    <Sample-Ref ref="GSM627070" />
    <Sample-Ref ref="GSM1404208" />
    <Sample-Ref ref="GSM1404209" />
    <Sample-Ref ref="GSM1404210" />
    <Sample-Ref ref="GSM1404211" />
    <Sample-Ref ref="GSM1404212" />
    <Sample-Ref ref="GSM1404213" />
    <Sample-Ref ref="GSM1404214" />
    <Sample-Ref ref="GSM1404215" />
    <Sample-Ref ref="GSM1404216" />
    <Sample-Ref ref="GSM1404217" />
    <Sample-Ref ref="GSM1404218" />
    <Sample-Ref ref="GSM1404219" />
    <Sample-Ref ref="GSM1404220" />
    <Sample-Ref ref="GSM1404221" />
    <Sample-Ref ref="GSM1404222" />
    <Sample-Ref ref="GSM1404223" />
    <Sample-Ref ref="GSM1404224" />
    <Sample-Ref ref="GSM1404225" />
    <Sample-Ref ref="GSM1404226" />
    <Sample-Ref ref="GSM1404227" />
    <Sample-Ref ref="GSM1404228" />
    <Sample-Ref ref="GSM1404229" />
    <Sample-Ref ref="GSM1404230" />
    <Sample-Ref ref="GSM1404231" />
    <Sample-Ref ref="GSM1404232" />
    <Sample-Ref ref="GSM1404233" />
    <Sample-Ref ref="GSM1404234" />
    <Sample-Ref ref="GSM1404235" />
    <Sample-Ref ref="GSM1404236" />
    <Sample-Ref ref="GSM1404237" />
    <Sample-Ref ref="GSM1404238" />
    <Sample-Ref ref="GSM1404239" />
    <Sample-Ref ref="GSM1404240" />
    <Sample-Ref ref="GSM1404241" />
    <Sample-Ref ref="GSM1404242" />
    <Sample-Ref ref="GSM1404243" />
    <Sample-Ref ref="GSM1404244" />
    <Sample-Ref ref="GSM1404245" />
    <Sample-Ref ref="GSM1404246" />
    <Sample-Ref ref="GSM1404247" />
    <Sample-Ref ref="GSM1404248" />
    <Sample-Ref ref="GSM1404249" />
    <Sample-Ref ref="GSM1404250" />
    <Sample-Ref ref="GSM1404251" />
    <Sample-Ref ref="GSM1404252" />
    <Sample-Ref ref="GSM1404253" />
    <Sample-Ref ref="GSM1404254" />
    <Sample-Ref ref="GSM1404255" />
    <Sample-Ref ref="GSM1404256" />
    <Sample-Ref ref="GSM1404257" />
    <Sample-Ref ref="GSM1404258" />
    <Sample-Ref ref="GSM1404259" />
    <Sample-Ref ref="GSM1404260" />
    <Sample-Ref ref="GSM1404261" />
    <Sample-Ref ref="GSM1404262" />
    <Sample-Ref ref="GSM1404263" />
    <Sample-Ref ref="GSM1404264" />
    <Sample-Ref ref="GSM1404265" />
    <Sample-Ref ref="GSM1404266" />
    <Sample-Ref ref="GSM1404267" />
    <Sample-Ref ref="GSM1404268" />
    <Sample-Ref ref="GSM1404269" />
    <Sample-Ref ref="GSM1404270" />
    <Sample-Ref ref="GSM1404271" />
    <Sample-Ref ref="GSM1404272" />
    <Sample-Ref ref="GSM1404273" />
    <Sample-Ref ref="GSM1404274" />
    <Sample-Ref ref="GSM1404275" />
    <Sample-Ref ref="GSM1404276" />
    <Sample-Ref ref="GSM1404277" />
    <Sample-Ref ref="GSM1404278" />
    <Sample-Ref ref="GSM1404279" />
    <Sample-Ref ref="GSM1404280" />
    <Sample-Ref ref="GSM1404281" />
    <Sample-Ref ref="GSM1404282" />
    <Sample-Ref ref="GSM1404283" />
    <Sample-Ref ref="GSM1404284" />
    <Sample-Ref ref="GSM1404285" />
    <Sample-Ref ref="GSM1404286" />
    <Sample-Ref ref="GSM1404287" />
    <Sample-Ref ref="GSM1404288" />
    <Sample-Ref ref="GSM1404289" />
    <Sample-Ref ref="GSM1404290" />
    <Sample-Ref ref="GSM1404291" />
    <Sample-Ref ref="GSM1404292" />
    <Sample-Ref ref="GSM1404293" />
    <Sample-Ref ref="GSM1404294" />
    <Sample-Ref ref="GSM1404295" />
    <Sample-Ref ref="GSM1404296" />
    <Sample-Ref ref="GSM1404297" />
    <Sample-Ref ref="GSM1404298" />
    <Sample-Ref ref="GSM1404299" />
    <Sample-Ref ref="GSM1404300" />
    <Sample-Ref ref="GSM1404301" />
    <Sample-Ref ref="GSM1404302" />
    <Sample-Ref ref="GSM1404303" />
    <Sample-Ref ref="GSM1404304" />
    <Sample-Ref ref="GSM1404305" />
    <Sample-Ref ref="GSM1404306" />
    <Sample-Ref ref="GSM1404307" />
    <Sample-Ref ref="GSM1404308" />
    <Sample-Ref ref="GSM1404309" />
    <Sample-Ref ref="GSM1404310" />
    <Sample-Ref ref="GSM1404311" />
    <Sample-Ref ref="GSM1404312" />
    <Sample-Ref ref="GSM1404313" />
    <Sample-Ref ref="GSM1404314" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE25nnn/GSE25504/suppl/GSE25504_RAW.tar
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE25nnn/GSE25504/suppl/GSE25504_non-normalized_data.txt.gz
    </Supplementary-Data>
    <Relation type="BioProject" target="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA134645" />
  </Series>

</MINiML>
